TDAC

Translational Development Acquisition Corp. is a special purpose acquisition company (SPAC) formed to effect a merger, capital stock exchange, asset acquisition, or similar business combination. The SPAC targets businesses in the healthcare and life sciences sectors, particularly those focused on translational medicine and innovative therapies. TDAC seeks to identify and partner with companies that can benefit from public market access and growth capital.